292 related articles for article (PubMed ID: 36497097)
1. Do Tumor Mechanical Stresses Promote Cancer Immune Escape?
Onwudiwe K; Najera J; Siri S; Datta M
Cells; 2022 Nov; 11(23):. PubMed ID: 36497097
[TBL] [Abstract][Full Text] [Related]
2. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
3. EMT-induced immune evasion: connecting the dots from mechanisms to therapy.
Imodoye SO; Adedokun KA
Clin Exp Med; 2023 Dec; 23(8):4265-4287. PubMed ID: 37966552
[TBL] [Abstract][Full Text] [Related]
4. Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy.
Zhang T; Jia Y; Yu Y; Zhang B; Xu F; Guo H
Adv Drug Deliv Rev; 2022 Jul; 186():114319. PubMed ID: 35545136
[TBL] [Abstract][Full Text] [Related]
5. New insights into the role of EMT in tumor immune escape.
Terry S; Savagner P; Ortiz-Cuaran S; Mahjoubi L; Saintigny P; Thiery JP; Chouaib S
Mol Oncol; 2017 Jul; 11(7):824-846. PubMed ID: 28614624
[TBL] [Abstract][Full Text] [Related]
6. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
Chouaib S
Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
[TBL] [Abstract][Full Text] [Related]
7. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
8. Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
Taki M; Abiko K; Ukita M; Murakami R; Yamanoi K; Yamaguchi K; Hamanishi J; Baba T; Matsumura N; Mandai M
Clin Cancer Res; 2021 Sep; 27(17):4669-4679. PubMed ID: 33827891
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
[TBL] [Abstract][Full Text] [Related]
11. Interaction between tumor microenvironment, autophagy, and epithelial-mesenchymal transition in tumor progression.
Wang WM; Shen H; Liu ZN; Chen YY; Hou LJ; Ding Y
Cancer Treat Res Commun; 2022; 32():100592. PubMed ID: 35728404
[TBL] [Abstract][Full Text] [Related]
12. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
Prasad M; Zorea J; Jagadeeshan S; Shnerb AB; Mathukkada S; Bouaoud J; Michon L; Novoplansky O; Badarni M; Cohen L; Yegodayev KM; Tzadok S; Rotblat B; Brezina L; Mock A; Karabajakian A; Fayette J; Cohen I; Cooks T; Allon I; Dimitstein O; Joshua B; Kong D; Voronov E; Scaltriti M; Carmi Y; Conde-Lopez C; Hess J; Kurth I; Morris LGT; Saintigny P; Elkabets M
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35292516
[TBL] [Abstract][Full Text] [Related]
13. The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response.
Wang G; Xu D; Zhang Z; Li X; Shi J; Sun J; Liu HZ; Li X; Zhou M; Zheng T
NPJ Precis Oncol; 2021 Jun; 5(1):56. PubMed ID: 34158591
[TBL] [Abstract][Full Text] [Related]
14. ZEB1 transcription factor promotes immune escape in melanoma.
Plaschka M; Benboubker V; Grimont M; Berthet J; Tonon L; Lopez J; Le-Bouar M; Balme B; Tondeur G; de la Fouchardière A; Larue L; Puisieux A; Grinberg-Bleyer Y; Bendriss-Vermare N; Dubois B; Caux C; Dalle S; Caramel J
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288462
[TBL] [Abstract][Full Text] [Related]
15. EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction.
Akalay I; Janji B; Hasmim M; Noman MZ; Thiery JP; Mami-Chouaib F; Chouaib S
Autophagy; 2013 Jul; 9(7):1104-6. PubMed ID: 23635487
[TBL] [Abstract][Full Text] [Related]
16. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression.
Saleh R; Elkord E
Semin Cancer Biol; 2020 Oct; 65():13-27. PubMed ID: 31362073
[TBL] [Abstract][Full Text] [Related]
17. A Darwinian perspective on tumor immune evasion.
Puleo J; Polyak K
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188671. PubMed ID: 34933050
[TBL] [Abstract][Full Text] [Related]
18. Alleviating hypoxia to improve cancer immunotherapy.
Fan P; Zhang N; Candi E; Agostini M; Piacentini M; ; Shi Y; Huang Y; Melino G
Oncogene; 2023 Dec; 42(49):3591-3604. PubMed ID: 37884747
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
20. Molecular cancer cell responses to solid compressive stress and interstitial fluid pressure.
Purkayastha P; Jaiswal MK; Lele TP
Cytoskeleton (Hoboken); 2021 Jun; 78(6):312-322. PubMed ID: 34291887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]